Session Information
Date: Sunday, October 21, 2018
Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities
Session Type: ACR Poster Session A
Session Time: 9:00AM-11:00AM
Background/Purpose: During the last 20 years, the treatment in rheumatoid arthritis (RA) has changed. Considering the increasing use of biological immunomodulators to treat chronic inflammatory conditions and the concern that immunomodulation may alter cancer risk and progression, it’s important to know the tumors incidence in patients with RA. The objective of this study was to analyze the incidence and trend of hospital admissions for solid tumors in patients with RA in Spain during the period between 1999 and 2015.
Methods: This is a retrospective population based study. We have analized a national administrative database that includes a Minimum Basic Data Set (MBDS) of hospital admissions of RA patients during the period 1999 to 2015. We selected the MBDS for solid tumors (breast, colon, pancreas, prostate, lung, pleura, melanoma, ovary, cervix, uterus, bladder and kidney). Cases were identified by the presence in primary and secondary diagnosis of ICD 9 codes. The population at risk was estimated through the population census of the National Institute of Statistics, with an estimated prevalence of RA of 0,5% (0,8% in women and 0,2% in men). Crude and adjusted rates of the solid tumors were calculated, and the trend was analyzed using the Generalized Linear Model (GLM) with the year as the analysis variable.
Results:338.343 RA hospital admissions were detected in the study period, being 18.401 (5,4%) due to solid tumors. The main clinical-demographic characteristics are shown in the next table.
|
Total |
Women |
Men |
P value |
N (%) |
18.401 (5,4) |
8689 (3,8) |
9712 (8,6) |
P<0,001 |
Age, mean (SD) |
69,98 (11,21) |
68,62 (12,3) |
71,20 (9,99) |
P<0,001 |
In-hospital exitus n (%) |
2455 (13,34) |
1035 (11,9) |
1420 (14,62) |
P<0,001 |
Charlson Index, mean (SD) |
5,72 (2,95) |
5,63 (2,95) |
5,80 (2,95) |
P<0,001 |
Stay, mean (SD) |
10,94 (11,6) |
10,76 (11,6) |
11,1 (11,77) |
P=0,051 |
The solid tumor adjusted rate during the study period was 647,53/105 inhabitants/yr (366,97/105 in women and 1792,99/105 in men; relative risk men:women =4,8). This rate increased from 305,65/105 in 1999 to 993,19/105 inhabitants/yr in 2015 (814,06/105 in 1999 to 2535,5/105 in 2015 in men and from 181,68/105 in 1999 to 607,71/105 in 2015 in women). The annual age-adjusted rate increased significantly: 7,37% (6,52% in men and 8,02% in women; p≤0,001).
Figure 1.
Conclusion: There was an increasing incidence of hospital admissions due to solid tumors in RA in Spain during the period 1999-2015. An annual rate increase of 7.37%, is estimated.
To cite this abstract in AMA style:
Villaverde García V, Fernández M, Mazzucchelli R, Macia-Villa C, Candelas G, Quirós J, Peña M, Perez-Fernandez E, Crespí N, Garcia-Vadillo A, Barbadillo C, Morell-Hita JL, Godoy H, Espinosa M, Morado-Quiñoa C, Martinez-Prada C, Galindo M, Guzon-Illescas O, Herranz A. Trends in the Incidence of SOLID Tumors in Patients with Rheumatoid Arthritis in Spain. a National Observational Cohort Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/trends-in-the-incidence-of-solid-tumors-in-patients-with-rheumatoid-arthritis-in-spain-a-national-observational-cohort-study/. Accessed .« Back to 2018 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/trends-in-the-incidence-of-solid-tumors-in-patients-with-rheumatoid-arthritis-in-spain-a-national-observational-cohort-study/